Linked from

The 12 pages that link to Deprescribing, each with the reason it gives.

• Adverse drug reactionRelated: A serious or persistent reaction may make supervised dose reduction or discontinuation appropriate.

• Physical dependenceRelated: Clinicians must balance ongoing medication risks against withdrawal and the pace of discontinuation.

• Benzodiazepine dependenceNarrower topic: Benzodiazepine tapering is a specific form of deprescribing that balances withdrawal risk against ongoing harms.

• Tricyclic antidepressantRelated: Long-term use may warrant review because adverse effects and treatment needs can change over time.

• Combination therapyCompared with: It counters unnecessary medication accumulation in patients receiving multiple treatments.

• PsychopharmacologyCompared with: Psychopharmacology also concerns safe withdrawal and avoiding unnecessary long-term treatment.

• AnticholinergicRelated: Reducing unnecessary anticholinergic medicines is a practical response to potential cumulative harms.

• HypnoticRelated: Gradual deprescribing can help manage withdrawal and rebound insomnia after prolonged use.

• PharmacotherapyCompared with: It shows that sound pharmacotherapy can mean stopping a medication.

• EsomeprazoleRelated: Reassessing ongoing need helps limit unnecessary long-term proton-pump inhibitor exposure.

• GeriatricsRelated: It provides a structured response to medication burden and changing goals.

• Frailty syndromeRelated: Medication review can reduce treatment burden and adverse effects in vulnerable patients.